Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 25, 2016
Prediction of Ketoconazole absorption using an updated in vitro transfer model coupled to physiologically based pharmacokinetic modellingAaron Ruff, Tom Fiolka, Edmund S Kostewicz
The Journal of Pediatrics|January 1, 1978
Hepatitis B in children. I. Analysis of 80 cases of acute and chronic hepatitis BJ M Dupuy, E Kostewicz, D Alagille
The Behavior Analyst|April 6, 2012
An initial survey of fractional graph and table area in behavioral journalsRichard M Kubina, Douglas E Kostewicz, Shawn M Datchuk
Behavior Analysis in Practice|October 11, 2021
Quantifying Function with the Functional Analysis Celeration ChartRichard M Kubina, Salvador Ruiz, Douglas E Kostewicz
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|October 31, 2007
[Ten years of experience with laparoscopic cholecystectomy]Jan K Purtak, Waldemar J Kostewicz, Tadeusz Mularczyk
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|January 1, 1997
[Iatrogenic reasons for conversion after laparoscopic cholecystectomy]M Kielar, W Kostewicz, P Myrcha, et al.
Polskie Archiwum Medycyny Wewnetrznej|July 3, 2004
[Prevalence of abdominal aortic aneurysm and peripheral arterial diseases in ambulatory patients with coronary disease]Tomasz Pasierski, Waldemar Kostewicz, Jarosław Rosłon, et al.
The Analysis of Verbal Behavior|April 6, 2012
General outcome measures for verbal operantsRichard M Kubina, Pamela Wolfe, Douglas E Kostewicz
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 24, 2001
False aneurysms of the proximal anastomosis of the arterial prosthesis and the abdominal aortaW Noszczyk, H Bielska, W Kostewicz, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 16, 2020
A combined in vitro in-silico approach to predict the oral bioavailability of borderline BCS Class II/IV weak base albendazole and its main metabolite albendazole sulfoxideMaximo Pettarin, Michael B Bolger, Maja Chronowska, et al.
Pageof 6